Transriptome analysis of LNCaP/AR cell line after concomittant treatment with androgen with bicalutamide and enzalutamide. Homo sapiens
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Transriptome analysis of LNCaP/AR cell line after concomittant treatment with androgen with bicalutamide and enzalutamide Overall design: LNCaP/AR cells growing in log phase were treated for 24 hours with vehicle, the androgen DHT, and DHT plus either bicalutamide or enzalutamide for 24 hours.
创建时间：
2014-10-17
